Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 09/01/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/
Kin Health | $9,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Hellbender Inc. | $12,500,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
viktor.com | $75,000,000 | (May 20, 2026)
Brami Inc. | $33,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Blank Bio | $7,200,000 | (May 20, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)